56 Results for "

fXa

" in MedChemExpress (MCE) Product Catalog:
Products (56)

56 Results for "fXa" in MCE Product Catalog:

16
16 Cited Publications
Cat. No.: HY-50903
CAS No.: 366789-02-8
Synonyms: BAY 59-7939
Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease Cancer

Rivaroxaban (BAY 59-7939) is a highly potent, selective and direct Factor Xa (FXa) inhibitor, achieving a strong gain in anti-FXa potency (IC50 0.7 nM; Ki 0.4 nM) .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-10264
CAS No.: 480449-70-5
Purity:  99.81%
Synonyms: DU-176
Target:  

Factor Xa Thrombin

Research Areas:  

Cardiovascular Disease Cancer

Edoxaban (DU-176b) is an orally active, highly potent, selective, and direct Factor Xa (FXa) inhibitor with Ki values of 0.561 and 2.98 nM for free human FXa and prothrombinase. Edoxaban exhibits more than 10,000-fold selectivity over other coagulation proteases. Edoxaban can be used in preventing thromboembolic disease research .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-10264A
CAS No.: 480449-71-6
Purity:  99.84%
Synonyms: DU-176b
Target:  

Factor Xa Thrombin

Research Areas:  

Cardiovascular Disease Cancer

Edoxaban (DU-176b) tosylate is an orally active, highly potent, selective, and direct Factor Xa (FXa) inhibitor with Kis of 0.561 and 2.98 nM for free human FXa and prothrombinase. Edoxaban tosylate exhibits more than 10,000-fold selectivity over other coagulation proteases. Edoxaban tosylate can be used for preventing thromboembolic disease research .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-10264B
CAS No.: 1229194-11-9
Purity:  99.97%
Synonyms: DU-176b monohydrate
Target:  

Factor Xa Thrombin

Research Areas:  

Cardiovascular Disease Cancer

Edoxaban (DU-176b) monohydrate is an orally active, highly potent, selective, and direct Factor Xa (FXa) inhibitor with Kis of 0.561 and 2.98 nM for free human FXa and prothrombinase. Edoxaban monohydrate exhibits more than 10,000-fold selectivity over other coagulation proteases. Edoxaban monohydrate can be used for preventing thromboembolic disease research .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-10268
CAS No.: 330942-05-7
Purity:  98.02%
Synonyms: PRT054021
Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

Betrixaban (PRT054021) is a highly potent, selective, and orally efficacious factor Xa (fXa) inhibitor with an IC50 of 1.5 nM. Betrixaban shows antithrombotic effect .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-10268A
CAS No.: 936539-80-9
Purity:  99.78%
Synonyms: PRT054021 maleate
Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

Betrixaban (PRT054021) maleate is a highly potent, selective, and orally efficacious factor Xa (fXa) inhibitor with an IC50 of 1.5 nM. Betrixaban maleate shows antithrombotic effect .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-N1745A
CAS No.: 112408-67-0
3-Deoxysappanchalcone is a natural chalcone compound isolated from the heartwood of Caesalpinia sappan L. 3-Deoxysappanchalcone induces cell cycle arrest, ROS production, and apoptosis. 3-Deoxysappanchalcone exhibits anti-inflammatory, anti-allergic, anticoagulant, and antithrombotic activities. 3-Deoxysappanchalcone is applicable to research related to lung cancer, esophageal squamous cell carcinoma, thrombosis, and influenza virus infection .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-50903S
CAS No.: 1132681-38-9
Synonyms: BAY 59-7939-d4
Rivaroxaban-d4 (BAY 59-7939-d4) is a deuterium labeled Rivaroxaban. Rivaroxaban is a highly potent,selective and direct Factor Xa (FXa) inhibitor, achieving a strong gain in anti-FXa potency (IC50 0.7 nM; Ki 0.4 nM) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P99283
CAS No.: 1312299-39-0
Synonyms: NN 7415; mAb 2021; Anti-TFPI Recombinant Antibody

Target:  

Factor Xa

Research Areas:  

Others

Concizumab is an anti-TFPI monoclonal antibody (IgG4 type) that binds to the Kunitz-type protease inhibitor (KPI) 2 structural domain of TFPI, thereby blocking the interaction of this structural domain with the FXa active site. Concizumab can be used in the study of haemophilia .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-70035
CAS No.: 193153-04-7
Synonyms: FXV673
Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

Otamixaban(FXV673) is a potent (Ki = 0.5 nM), selective, rapid acting, competitive and reversible fXa inhibitor that effectively inhibits both free and prothrombinase-bound fXa.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P2008
CAS No.: 65147-06-0
Synonyms: IEGR-AMC
Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

Boc-Ile-Glu-Gly-Arg-AMC (IEGR-AMC) is an activated factor X (FXa) specific fluorogenic peptide substrate used for Factor VIII determination .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N2082
CAS No.: 6743-92-6
Synonyms: Cacticin
Isorhamnetin 3-O-galactoside (Cacticin) is a flavonoid glycoside that can be isolated from Oenanthe javanica, with antithrombotic and profibrinolytic activities. Isorhamnetin 3-O-galactoside inhibits the activities of thrombin and factor Xa (FXa) and reduces thrombin-catalyzed fibrin polymerization maximum rate. Isorhamnetin 3-O-galactoside suppresses TNF-α-induced PAI-1 secretion, decreases the PAI-1/tissue-type plasminogen activator (t-PA) ratio, and inhibits FXa production and FVa/FXa-mediated thrombin generation. Isorhamnetin 3-O-galactoside exerts protective effects against Carbon tetrachloride (CCl4) (HY-Y0298)-induced hepatic injury in mice. Isorhamnetin 3-O-galactoside can be used for the study of liver injury-related diseases and thrombotic vascular diseases .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-76948
CAS No.: 865479-71-6
Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

5-R-Rivaroxaban is (R)-enantiomer of Rivaroxaban. Rivaroxaban (BAY 59-7939) is a highly potent and selective, direct Factor Xa (FXa) inhibitor, achieving a strong gain in anti-FXa potency (IC50 0.7 nM; Ki 0.4 nM).
loading...
    loading...
Cat. No.: HY-75680
CAS No.: 503614-91-3
Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

Apixaban ethyl ester is a key intermediate in the synthesis of FXa inhibitors, which is used to study the inhibitory activity against venous thrombosis .
loading...
    loading...
Cat. No.: HY-10264R
CAS No.: 480449-70-5
Synonyms: DU-176 (Standard)
Edoxaban (Standard) is the analytical standard of Edoxaban. This product is intended for research and analytical applications. Edoxaban (DU-176b) is an orally active, highly potent, selective, and direct Factor Xa (FXa) inhibitor with Ki values of 0.561 and 2.98 nM for free human FXa and prothrombinase. Edoxaban exhibits more than 10,000-fold selectivity over other coagulation proteases. Edoxaban can be used in preventing thromboembolic disease research .
loading...
    loading...
Cat. No.: HY-50903R
CAS No.: 366789-02-8
Synonyms: BAY 59-7939 (Standard)
Rivaroxaban (Standard) is the analytical standard of Rivaroxaban. This product is intended for research and analytical applications. Rivaroxaban (BAY 59-7939) is a highly potent, selective and direct Factor Xa (FXa) inhibitor, achieving a strong gain in anti-FXa potency (IC50 0.7 nM; Ki 0.4 nM) .
loading...
    loading...
Cat. No.: HY-10264S
CAS No.: 1304701-57-2
Purity:  ≥99.0%
Synonyms: DU-176-d6
Edoxaban-d6 is deuterium labeled Edoxaban. Edoxaban (DU-176) is a selective, potent and orally active factor Xa (FXa) inhibitor with Kis of 0.561 nM and 2.98 nM for free FXa and prothrombinase, respectively. Edoxaban is an anticoagulant agent and can be used for stroke prevention. Edoxaban is also a weak inhibitor of thrombin and factor IXaβ (FIXa), with Kis of 6.00 μM and 41.7 μM, respectively, exhibits >10000-fold selectivity for FXa. Edoxaban has antithrombotic properties and has potential for thromboembolic diseases treatment .
loading...
    loading...
Cat. No.: HY-134685
CAS No.: 480452-37-7
Target:  

Factor Xa Thrombin

Research Areas:  

Cardiovascular Disease

Edoxaban impurity 6 is an impurity of Edoxaban. Edoxaban (DU-176) is a selective, potent and orally active factor Xa (FXa) inhibitor with Kis of 0.561 nM and 2.98 nM for free FXa and prothrombinase, respectively. Edoxaban is an anticoagulant agent and can be used for stroke prevention .
loading...
    loading...
Cat. No.: HY-134686
CAS No.: 480452-36-6
Purity:  99.08%
Target:  

Factor Xa Thrombin

Research Areas:  

Cardiovascular Disease

Edoxaban impurity 4 is an impurity of Edoxaban. Edoxaban (DU-176) is a selective, potent and orally active factor Xa (FXa) inhibitor with Kis of 0.561 nM and 2.98 nM for free FXa and prothrombinase, respectively. Edoxaban is an anticoagulant agent and can be used for stroke prevention .
loading...
    loading...
Cat. No.: HY-10267
CAS No.: 536748-46-6
Purity:  98.52%
Synonyms: PD-0348292
Target:  

Factor Xa

Research Areas:  

Cardiovascular Disease

Eribaxaban (PD-0348292) is an orally active and selective FXa inhibitor with a Ki value of 0.32 nM. Eribaxaban reduces thrombus formation .
loading...
    loading...